JP2018520201A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520201A5
JP2018520201A5 JP2018503142A JP2018503142A JP2018520201A5 JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5 JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
amino
triazin
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018503142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/043252 external-priority patent/WO2017015425A1/en
Publication of JP2018520201A publication Critical patent/JP2018520201A/ja
Publication of JP2018520201A5 publication Critical patent/JP2018520201A5/ja
Pending legal-status Critical Current

Links

JP2018503142A 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト Pending JP2018520201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562195854P 2015-07-23 2015-07-23
US62/195,854 2015-07-23
PCT/US2016/043252 WO2017015425A1 (en) 2015-07-23 2016-07-21 Tgf beta receptor antagonists

Publications (2)

Publication Number Publication Date
JP2018520201A JP2018520201A (ja) 2018-07-26
JP2018520201A5 true JP2018520201A5 (cg-RX-API-DMAC7.html) 2019-08-15

Family

ID=56609944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503142A Pending JP2018520201A (ja) 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト

Country Status (6)

Country Link
US (1) US10336761B2 (cg-RX-API-DMAC7.html)
EP (1) EP3325484A1 (cg-RX-API-DMAC7.html)
JP (1) JP2018520201A (cg-RX-API-DMAC7.html)
KR (1) KR20180032611A (cg-RX-API-DMAC7.html)
CN (1) CN108026105B (cg-RX-API-DMAC7.html)
WO (1) WO2017015425A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018012914B1 (pt) 2015-12-22 2023-04-18 SHY Therapeutics LLC Composto, uso de um composto e composição farmacêutica
AU2018288841B2 (en) 2017-06-21 2022-09-29 SHY Therapeutics LLC Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic disease
WO2019084463A1 (en) * 2017-10-26 2019-05-02 Southern Research Institute OXADIAZOLES AND THIADIAZOLES AS INHIBITORS OF TGF-BETA
WO2020132071A1 (en) 2018-12-19 2020-06-25 Shy Therapeutics. Llc Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and f1brotic disease
KR102832376B1 (ko) 2018-12-27 2025-07-09 넥시스 테라퓨틱스 인코포레이티드 암의 치료를 위한 tgf-베타 r1(alk5) 억제제로서의(피리딘-2-일)아민 유도체
CN111825675B (zh) * 2019-04-15 2023-08-01 武汉朗来科技发展有限公司 Rock抑制剂及其制备方法和用途
CN112694477B (zh) * 2019-10-22 2024-02-06 四川科伦博泰生物医药股份有限公司 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途
WO2021147699A1 (zh) * 2020-01-21 2021-07-29 四川科伦博泰生物医药股份有限公司 吡啶并杂环类化合物、其制备方法及用途
CN113620956B (zh) * 2020-05-06 2023-06-13 赛诺哈勃药业(成都)有限公司 转化生长因子受体拮抗剂、其制备方法和应用
JP2025512935A (ja) * 2022-04-08 2025-04-22 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリータンパク質と相互作用する化合物
MA71454A (fr) * 2022-07-14 2025-04-30 Biogen Ma Inc. Inhibiteurs de tyrosine kinase 2 et leurs utilisations
WO2024155834A1 (en) * 2023-01-19 2024-07-25 Skyhawk Therapeutics, Inc. Compositions useful for modulating splicing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR041134A1 (es) * 2002-09-04 2005-05-04 Schering Corp Pirazolopirimidinas como inhibidores de la quinasa dependiente de ciclina
WO2004065392A1 (en) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
WO2004087056A2 (en) * 2003-03-28 2004-10-14 Scios Inc. BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
AU2012224979B2 (en) * 2011-03-09 2017-01-19 Merck Patent Gmbh Pyrido [2, 3 - b] pyrazine derivatives and their therapeutical uses
CN103450204B (zh) * 2012-05-31 2016-08-17 中国科学院上海药物研究所 吡咯[2,1-f][1,2,4]并三嗪类化合物,其制备方法及用途

Similar Documents

Publication Publication Date Title
JP2018520201A5 (cg-RX-API-DMAC7.html)
US8871753B2 (en) Macrocyclic compounds and their use as kinase inhibitors
RU2425826C2 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb
US9221809B2 (en) Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
US9382241B2 (en) Aminoquinazoline and pyridopyrimidine derivatives
JP2011518836A5 (cg-RX-API-DMAC7.html)
JP2013544256A5 (cg-RX-API-DMAC7.html)
RU2013124101A (ru) Гетероциклические амины и их применения
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
RU2010137300A (ru) Модуляторы бета-амилоида
KR20210040368A (ko) 사이클린 의존성 키나제의 억제제
JP2021502356A5 (cg-RX-API-DMAC7.html)
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
RU2009121564A (ru) Азаадамантановые производные и способы применения
JP2015528022A5 (cg-RX-API-DMAC7.html)
JP2016523911A5 (cg-RX-API-DMAC7.html)
JPWO2020201773A5 (cg-RX-API-DMAC7.html)
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
RU2009147733A (ru) Пиридилпиперидновые антагонисты рецептора орексинов
RU2015111133A (ru) Ингибиторы тирозинкиназы брутона
CA2422923A1 (en) Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity
JP2013533300A (ja) ブルトン型チロシンキナーゼの阻害剤
KR20170049609A (ko) Tank-결합 키나제 억제제 화합물로서 유용한 아미노트리아진 유도체
JPWO2005063743A1 (ja) チアゾール誘導体
ES2557478T3 (es) Compuestos de pirazol y triazol como inhibidores de KSP